Entrada Therapeutics, Inc. (TRDA) Insider Trading

Name: Entrada Therapeutics, Inc. (TRDA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 9, 2026): MPM BIOVENTURES 2018, L.P. (10% Owner): Sale of 38,500 shares, $273.7K.

Get alerted when insiders trade TRDA

Email address

Loading company data...

Loading company details...